Browse the complete record of transactions filed by Wagner Charles F Jr, 首席财务官. Director active across 2 companies, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 39 disclosures have been logged. Split: 0 buy · 13 sells. Total volume traded: €12m. Activity tracked since 30 April 2021. The latest transaction was filed on 24 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Wagner Charles F Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Directeur Financier, WAGNER CHARLES F JR has filed 39 filings. Across the sampled recent filings from 2021-05-05 to 2026-02-26, the total reported sales amount is EUR 11957529 and the most frequent transaction nature is Retenue fiscale.